Sanofi names Prof Bassler to board
This article was originally published in Scrip
Sanofi has nominated Professor Bonnie L Basslerto an independent member of its board of directors. Professor Bassler, 52, is a Howard Hughes Medical Institute investigator, the Squibb Professor in molecular biology, and the chair of the department of molecular biology at Princeton University, New Jersey. Furthermore, Professor Bassler was appointed a member of the US National Science Board by President Barack Obama in 2011. She also serves on oversight, grant, fellowship and award panels for organizations including the National Academies of Sciences, US National Institutes of Health, US National Science Foundation, American Society for Microbiology, Keck Foundation, Burroughs Wellcome Trust, Jane Coffin Childs Fund, PEW Charitable Trust, Gordon and Betty Moore Foundation, and the MIT Whitehead Institute.
You may also be interested in...
Coaching and mentoring are important tools for the leaders of today to be able to foster the next generation of talent in the biopharma sector. While the routes into industry have not changed dramatically – most leaders hold a master’s degree and/or PhD – the expectations of rising leaders have altered and the industry itself has become more collaborative.
Angeli Möller, recently spotlighted by In Vivo as a 2020 Rising Leader, has quickly moved up the ranks at Bayer and is now spearheading one of its key initiatives to bring artificial intelligence and machine learning technologies into the pharma business.
In this first edition of In Vivo's ‘Rising Leaders’ list, the focus is on entrepreneurs and innovators who represent the next wave of creativity in health care.